MSB 12.1% 55.5¢ mesoblast limited

Ann: Results Show Improved Survival in Children with GVHD, page-7

  1. 482 Posts.
    Yea but, this isn't exactly "news". We know that it was positive for pediatric GvHD, when they bought it from... what's their face again. They did a post trial analysis and found that it worked only really in children and that's how they got the conditional approval in Canada. This is merely confirmatory data
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
55.5¢
Change
0.060(12.1%)
Mkt cap ! $633.0M
Open High Low Value Volume
50.0¢ 59.0¢ 48.5¢ $16.88M 30.80M

Buyers (Bids)

No. Vol. Price($)
4 62700 55.5¢
 

Sellers (Offers)

Price($) Vol. No.
56.0¢ 40000 1
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
55.5¢
  Change
0.060 ( 15.7 %)
Open High Low Volume
50.5¢ 59.0¢ 48.5¢ 11524458
Last updated 16.02pm 29/03/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.